Invention Grant
- Patent Title: Modulators of FOXP3 expression
-
Application No.: US16684271Application Date: 2019-11-14
-
Publication No.: US11547718B2Publication Date: 2023-01-10
- Inventor: Alexey Revenko , Robert A. MacLeod , Susan M. Freier
- Applicant: Ionis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Main IPC: C07H21/02
- IPC: C07H21/02 ; A61K31/7125 ; A61P35/00 ; C12N15/113
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting FOXP3 expression, which may be useful for treating, preventing, or ameliorating cancer.
Public/Granted literature
- US20200179435A1 MODULATORS OF FOXP3 EXPRESSION Public/Granted day:2020-06-11
Information query
